Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
The Lancet. Oncology
|
January 16, 2015
Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data
Anne J Breugom, Marloes Swets, Jean-François Bosset, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 4, 2005
Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
Suzannah Mawdsley, Rob Glynne-Jones, Juliet Grainger, et al.
BMC Cancer
|
May 4, 2017
Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L)
Stuart A Taylor, Sue Mallett, Anne Miles, et al.
The Lancet. Oncology
|
August 10, 2010
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
Monique Maas, Patty J Nelemans, Vincenzo Valentini, et al.
International Journal of Cancer
|
November 25, 2014
Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients
Monique Maas, Patty J Nelemans, Vincenzo Valentini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2020
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct
Sheela Rao, Francesco Sclafani, Cathy Eng, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2017
3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer
Manfred P Lutz, John R Zalcberg, Michel Ducreux, et al.
British Journal of Cancer
|
September 7, 2016
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
Angus G Dalgleish, Justin Stebbing, Douglas Ja Adamson, et al.
British Journal of Cancer
|
October 12, 2016
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
Angus G Dalgleish, Justin Stebbing, Douglas J A Adamson, et al.
The Lancet. Oncology
|
May 7, 2025
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial
Alexandra Gilbert, Richard Adams, Joanne Webster, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
The Lancet. Oncology
|
January 16, 2015
Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data
Anne J Breugom, Marloes Swets, Jean-François Bosset, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 4, 2005
Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
Suzannah Mawdsley, Rob Glynne-Jones, Juliet Grainger, et al.
BMC Cancer
|
May 4, 2017
Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L)
Stuart A Taylor, Sue Mallett, Anne Miles, et al.
The Lancet. Oncology
|
August 10, 2010
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
Monique Maas, Patty J Nelemans, Vincenzo Valentini, et al.
International Journal of Cancer
|
November 25, 2014
Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients
Monique Maas, Patty J Nelemans, Vincenzo Valentini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2020
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct
Sheela Rao, Francesco Sclafani, Cathy Eng, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2017
3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer
Manfred P Lutz, John R Zalcberg, Michel Ducreux, et al.
British Journal of Cancer
|
September 7, 2016
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
Angus G Dalgleish, Justin Stebbing, Douglas Ja Adamson, et al.
British Journal of Cancer
|
October 12, 2016
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
Angus G Dalgleish, Justin Stebbing, Douglas J A Adamson, et al.
The Lancet. Oncology
|
May 7, 2025
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial
Alexandra Gilbert, Richard Adams, Joanne Webster, et al.
Page
of 9